- Ten-year experience with therapy of relapsing acute lymphoblastic leukemia in childhood1997 | Second Faculty of Medicine
- Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation2018 | Second Faculty of Medicine
- Other (Non-cns/testicular) extramedullary localizations of childhood relapsed acute lymphoblastic leukemia and lymphoblastic lymphoma-a report from the all-rez study group2021 | Second Faculty of Medicine
- CD38: A target in relapsed/refractory acute lymphoblastic leukemia-Limitations in treatment and diagnostics2022 | Second Faculty of Medicine
- Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group2013 | Second Faculty of Medicine
- Childhood secondary ALL after ALL treatment2007 | Second Faculty of Medicine, Central Library of Charles University
- Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia2015 | Second Faculty of Medicine
- Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment2015 | Second Faculty of Medicine
- The incidence and treatment of relapse of childhood acute lymphoblastic leukemia in the Czech Republic between 1990-20002003 | Second Faculty of Medicine
- Low rate of nonrelapse mortality in under 4-year-olds with ALL given chemo-conditioning for HSCT: Phase III FORUM study2024 | Second Faculty of Medicine